Acquisition Opportunity SystemLink has been acquired by Thermo Fisher Scientific, indicating potential alignment with Thermo Fisher’s broader HLA and lab software ecosystem. This suggests a sales pathway to Thermo Fisher customers seeking Histocompatibility and Immunogenetics solutions.

HLA Market Focus As an industry leader in HLA application development with a global customer base, SystemLink’s Histotrac software positions it to upsell integration, data management, and compliance features to biotechnology and immunogenetics labs seeking advanced HLA tools.

SMB to Enterprise Fit The company serves small to large laboratories, indicating flexible deployment, licensing, and support options that can be tailored for mid-market and enterprise accounts in need of scalable HLA software solutions.

Tech Stack Leverage Current tech stack (WordPress, MySQL, analytics, SEO tools) points to ease of digital marketing, self-service trials, and content-driven lead generation; opportunities exist to cross-sell enterprise-grade data security, integration, and analytics features.

Revenue Growth Path Revenue in the one-to-ten million range combined with recent acquisition hints at growth velocity; potential sales angles include licensed upgrades, premium support, and service-level agreements to expand wallet share within Thermo Fisher's installed base.